+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Therapeutic Vaccines Market By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell vaccine), By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025

  • ID: 5022660
  • Report
  • May 2020
  • Region: Global
  • 114 pages
  • TechSci Research

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Therapeutic Vaccines Market is Expected to Grow at a Double Digit CAGR During the Forecast Period.

FEATURED COMPANIES

  • Agenus Inc
  • Argos Therapeutics Inc
  • Bavarian Nordic A/S
  • Celldex Therapeutics Inc
  • CureVac GmbH
  • Novartis AG
  • MORE
The Global Therapeutic Vaccines Market is expected to grow at a double digit CAGR during the forecast period on account of increasing awareness in the population about prevalence of fatal and chronic diseases. Moreover, on account of increasing demand from consumers, 120 new vaccines are also anticipated to be introduced globally by different multinational companies, thereby driving the market. Since vaccines are prepared for a special type of disease, it can be said that the market is the demand-based market.

The Global Therapeutic Vaccines Market is segmented on the basis of type, product, technology, delivery mechanism, end-user, company and region. The type segment is further segregated into addiction vaccines, auto immune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccine and others. Auto immune disease vaccines held the largest market share in 2019 as auto immune diseases are responsible for majority of deaths all over the world.

In terms of regional analysis, Asia-Pacific is anticipated to grow at the highest rate until 2025 owing to increasing patient awareness and improving healthcare infrastructure. Moreover, favorable regulations and initiatives taken by the government in the economies present in the region are positively impacting the growth of the market.

Leading players in the Global Therapeutic Vaccines Market include Sanofi Pasteur SA de CV, Intellect Neurosciences Inc, Agenus Inc, Celtic Pharma Holdings Advisors LLC, Novartis AG, Bavarian Nordic A/S, Transgene SA, Argos Therapeutics Inc, Celldex Therapeutics Inc, CureVac GmbH, etc. The companies operating in the Global Therapeutic Vaccines Market are adoption inorganic and organic growth strategies to increase their share in the market.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and forecast the market size of the Global Therapeutic Vaccines Market.
  • To classify and forecast the Global Therapeutic Vaccines Market based on type, product, technology, delivery mechanism, end-user, company and region.
  • To identify drivers and challenges for the Global Therapeutic Vaccines Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Therapeutic Vaccines Market.
  • To conduct pricing analysis for the Global Therapeutic Vaccines Market.
  • To identify and analyze the profile of leading players operating in the Global Therapeutic Vaccines Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of manufacturers across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the manufacturers which could not be identified due to the limitations of secondary research. The author analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Therapeutic Vaccines Market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Therapeutic vaccines manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic vaccine
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Therapeutic Vaccines Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type:
  • Antigen Vaccine
  • Dendritic Cell Vaccine
  • DNA Vaccines
  • Tumor Cell Vaccine
Market, By Product:
  • Addiction Vaccines
  • Auto Immune Disease Vaccines
  • Neurological Disease Vaccines
  • Cancer Vaccines
  • Infectious Disease Vaccine
  • Others
Market, By Technology:
  • Autologous Vaccines
  • Allogeneic Vaccines
Market, By Delivery Mechanism:
  • Nasal
  • Electroporation
Market, By End-User:
  • Private Hospitals
  • Government Hospitals
  • Specialty Clinics
Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Vaccines Market.

Available Customizations:
With the given the market data, researchers offers customizations according to a company’s specific needs.

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agenus Inc
  • Argos Therapeutics Inc
  • Bavarian Nordic A/S
  • Celldex Therapeutics Inc
  • CureVac GmbH
  • Novartis AG
  • MORE
1. Product Overview

2. Research Methodology

3. Impact of COVID 19 on Global Therapeutic Vaccines Market

4. Voice of Customers

5. Executive Summary

6. Global Therapeutic Vaccines Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Antigen Vaccine, Dendritic Cell Vaccine, DNA Vaccines, Tumor cell vaccine)
6.2.2. By Product (Addiction Vaccines, Auto Immune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccine, Others)
6.2.3. By Technology (Autologous Vaccines, Allogeneic Vaccines)
6.2.4. By Delivery Mechanism (Nasal, Electroporation)
6.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)
6.2.6. By Company (2019)
6.2.7. By Region
6.3. Market Attractiveness Index

7. Asia-Pacific Therapeutic Vaccines Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Therapeutic Vaccines Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Technology
7.3.1.2.3. By End User
7.3.2. India Therapeutic Vaccines Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Technology
7.3.2.2.3. By End User
7.3.3. Japan Therapeutic Vaccines Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Technology
7.3.3.2.3. By End User
7.3.4. South Korea Therapeutic Vaccines Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Technology
7.3.4.2.3. By End User
7.3.5. Singapore Therapeutic Vaccines Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Technology
7.3.5.2.3. By End User
7.3.6. Australia Therapeutic Vaccines Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Product Type
7.3.6.2.2. By Technology
7.3.6.2.3. By End User

8. Europe Therapeutic Vaccines Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Therapeutic Vaccines Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Technology
8.3.1.2.3. By End User
8.3.2. Germany Therapeutic Vaccines Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Technology
8.3.2.2.3. By End User
8.3.3. United Kingdom Therapeutic Vaccines Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Technology
8.3.3.2.3. By End User
8.3.4. Italy Therapeutic Vaccines Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Technology
8.3.4.2.3. By End User
8.3.5. Spain Therapeutic Vaccines Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Technology
8.3.5.2.3. By End User

9. North America Therapeutic Vaccines Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Therapeutic Vaccines Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Technology
9.3.1.2.3. By End User
9.3.2. Mexico Therapeutic Vaccines Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Technology
9.3.2.2.3. By End User
9.3.3. Canada Therapeutic Vaccines Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Technology
9.3.3.2.3. By End User

10. South America Therapeutic Vaccines Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Therapeutic Vaccines Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Technology
10.3.1.2.3. By End User
10.3.2. Argentina Therapeutic Vaccines Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Technology
10.3.2.2.3. By End User
10.3.3. Colombia Therapeutic Vaccines Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Technology
10.3.3.2.3. By End User

11. Middle East and Africa Therapeutic Vaccines Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Technology
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Therapeutic Vaccines Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Technology
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Therapeutic Vaccines Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Technology
11.3.2.2.3. By End User
11.3.3. UAE Therapeutic Vaccines Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Technology
11.3.3.2.3. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges
12.3. Porter’s Five forces challenge

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Sanofi Pasteur SA de CV
14.2.2. Intellect Neurosciences Inc
14.2.3. Agenus Inc
14.2.4. Celtic Pharma Holdings Advisors LLC
14.2.5. Novartis AG
14.2.6. Bavarian Nordic A/S
14.2.7. Transgene SA
14.2.8. Argos Therapeutics Inc
14.2.9. Celldex Therapeutics Inc
14.2.10. CureVac GmbH

15. Strategic Recommendations

16. About Us & Disclaimer
Note: Product cover images may vary from those shown
  • Sanofi Pasteur SA de CV
  • Intellect Neurosciences Inc
  • Agenus Inc
  • Celtic Pharma Holdings Advisors LLC
  • Novartis AG
  • Bavarian Nordic A/S
  • Transgene SA
  • Argos Therapeutics Inc
  • Celldex Therapeutics Inc
  • CureVac GmbH
Note: Product cover images may vary from those shown
Adroll
adroll